Black Diamond Therapeutics Logo

Black Diamond Therapeutics

🇺🇸
BDTX
US09203E1055

Black Diamond Therapeutics is a US-based biotechnology company specializing in the development of precision oncology therapies. Using its proprietary MAP platform, the company identifies targeted genetic mutations to develop innovative cancer treatments for patients with high unmet medical needs.

Next Quarterly Earnings

Monday, November 9, 2026
CW 46
After-Hours
In 74 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 12, 2026

Stock Price

Frequently asked questions

When will Black Diamond Therapeutics report its next quarterly earnings?

Black Diamond Therapeutics is scheduled to report its next quarterly earnings on 11/09/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Black Diamond Therapeutics last report quarterly earnings?

Black Diamond Therapeutics last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.17 USD.

How often has Black Diamond Therapeutics beaten expectations?

Black Diamond Therapeutics has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).

How do I add the Black Diamond Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.11
Actual:
Q2 2026
Beat
Estimate:-$0.20
Actual:-$0.17
Difference:+$0.03
Q1 2026
Beat
Estimate:-$0.18
Actual:-$0.16
Difference:+$0.02
Price reaction (1 day):-3.6 %
Price reaction (7 days):+1.4 %
Q4 2025
Missed
Estimate:-$0.18
Actual:-$0.27
Difference:-$0.09
Price reaction (1 day):+1.8 %
Price reaction (7 days):-1.8 %
Q2 2025
Beat
Estimate:-$0.23
Actual:-$0.15
Difference:+$0.08
Q1 2025
Beat
Estimate:-$0.23
Actual:-$0.19
Difference:+$0.04

Earnings statistics

Estimates vs. results

4/5
Quarters above estimates
80%
Beat rate
-4.8%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Black Diamond Therapeutics
Ticker Symbol
BDTX
ISIN
US09203E1055
Country
🇺🇸
USA
Sector